Medical Device News Magazine

Sterling Partners and its Incubator ’87 Partner with Stella Center for Trauma Symptom Care

Sterling Chairman & Co-Founder Steven Taslitz and Team Are Working to Expand Access to Neurological Trauma Symptom Care

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Sterling Partners and its investment incubator ‘87 announced today the formation of a new managed services organization (MSO), Stella MSO, LLC, which will provide services to Stella Center, a new model of care for individuals seeking treatment of neurological trauma-related symptoms.

Stella Center provides care to patients with a 20-minute outpatient medical procedure called a modified Stellate Ganglion Block (SGB) that targets the brain’s fight or flight response to help alleviate symptoms related to neurological trauma. These symptoms range from relationship and sleep problems to panic attacks and surges of irritability and afflict those from all walks of life, including military personnel, veterans and first responders. The procedure and Stella Center draw on the years of experience of highly regarded, board-certified anesthesiologist and Stella Center’s Chief Medical Officer Dr. Eugene Lipov. Dr. Lipov has administered the SGB procedure more than 1,000 times in patients with trauma-related symptoms.

The formation of the MSO and its first partnership with a physical center for care, located just outside of downtown Chicago, was led by Sterling Partners (“Sterling”) Chairman and Co-Founder Steven Taslitz. Taslitz was introduced to Dr. Lipov and licensed psychologist and veteran trauma specialist Dr. Shauna Springer in early 2019, and together they sought to create a patient-first center designed to improve the lives of those impacted by trauma. Furthermore, the partnership complemented Taslitz’s desire to build and scale businesses that benefit veteran communities, just as his team did through an investment in Black Rifle Coffee Company. Together Dr. Lipov, Dr. Springer, Taslitz, and ‘87 are building a platform that could expand nationally to increase access to this method of care, and in communities with large concentrations of military personnel.

“The Department of Veterans Affairs estimates that Post-Traumatic Stress Disorder will affect 7% to 8% of the population at some point in life,” explained Taslitz. “When we were approached by Dr. Lipov to assist him in expanding his model that seeks to meaningfully improve people’s lives, we couldn’t help but roll up our sleeves. Stella Center is an opportunity for us to draw on our years of experience in healthcare investing and our entrepreneurial roots. We’re excited to be on the forefront of addressing the challenge of effective and scalable trauma-related symptom care.”

Through the creation of Stella’s MSO, Sterling and ’87 provide Stella Center strategic guidance on finance, talent, branding, and marketing. Sterling has nearly 40 years of investment and business-building experience and a long-standing practice in multi-unit healthcare services. With Sterling’s addition of ‘87, which brings expertise in growth marketing and brand building, the partnership with Stella Center seemed particularly well-suited. Dr. Lipov controls the center itself and the services provided there, alongside CEO James R. Williams. Williams, like Sterling, is a proven healthcare leader, having previously expanded and led U.S. care networks for companies including DaVita, Vein Clinics of America, Accelitech, and ProCure.

Stella Center’s first physical location is now open at 2425 22nd St., Suite 101, Oak Brook, IL, 60523. It is administering treatment as appropriate while adhering to physical distancing requirements. Its call center is also open to consult with potential patients and outline treatment options through its telehealth platform. With Drs. Lipov and Springer’s direction, Stella Center is evaluating opening new brick and mortar locations, focused in active duty and veteran-heavy geographies, and hiring top-tier clinical staff.

“This is a promising time in the advancement of care for the biological and neurological effects of trauma,” added Lipov. “I’m thrilled to be working with Sterling Partners and ’87, who have extensive experience in building great healthcare organizations and positive patient experiences. Our goal is to provide hope and healing to patients struggling with trauma-related symptoms.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”